Page last updated: 2024-08-24

5-methylcytosine and Aortic Valve Stenosis

5-methylcytosine has been researched along with Aortic Valve Stenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Argaud, D; Bossé, Y; Bouchard, L; Boulanger, MC; Gagné-Ouellet, V; Gaudreault, N; Hadji, F; Jalloul Nsaibia, M; Mathieu, P; Mkannez, G; Rhéaume, G; Rosa, M	1

Other Studies

1 other study(ies) available for 5-methylcytosine and Aortic Valve Stenosis

Article	Year
DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease. Cardiovascular research, 2018, 09-01, Volume: 114, Issue:11 Topics: 5-Methylcytosine; Aged; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Calcium; Case-Control Studies; CRISPR-Cas Systems; DNA Methylation; DNA Transposable Elements; Down-Regulation; Gene Editing; Gene Expression Profiling; HEK293 Cells; Humans; Lysophospholipids; Male; Middle Aged; Osteogenesis; Phosphatidate Phosphatase; Promoter Regions, Genetic	2018

Article

Year

DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease.

Cardiovascular research, 2018, 09-01, Volume: 114, Issue:11

Topics: 5-Methylcytosine; Aged; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Calcium; Case-Control Studies; CRISPR-Cas Systems; DNA Methylation; DNA Transposable Elements; Down-Regulation; Gene Editing; Gene Expression Profiling; HEK293 Cells; Humans; Lysophospholipids; Male; Middle Aged; Osteogenesis; Phosphatidate Phosphatase; Promoter Regions, Genetic

2018